Maria Feldman

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Maria Feldman

Unternehmen	Position	Beginn	Ende
Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	Geschäftsführer	01.03.2014	-
	Technik-/Wissenschafts-/F&E-Leiter	01.03.2014	-
	General Counsel	01.02.2016	-
EVOFEM BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	-	-
EVOFEM BIOSCIENCES, INC.	General Counsel	-	-
MEDICINOVA, INC.	General Counsel	01.01.2004	-

St. Olaf College

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
MEDICINOVA, INC.	Health Technology
EVOFEM BIOSCIENCES, INC.	Health Technology

Private Unternehmen	1
Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	Health Technology

Private Unternehmen

Health Technology